NCT06138613

Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness

Motion Delos: An Open Label Study to Investigate the Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness During Travel

• Status: Active Not Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 705 (actual)
• Sponsor: Vanda Pharmaceuticals · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

An open label study to investigate the safety and efficacy of tradipitant in participants affected by motion sickness during travel

Detailed description

This is an open label study to investigate the efficacy and safety of tradipitant in motion sickness affected male and female participants during events historically known to cause motion sickness.

Conditions

• Motion Sickness

Interventions

Type	Name	Description
DRUG	Tradipitant	Oral Capsule

Timeline

• Start date: 2023-02-27
• Primary completion: 2027-09-30
• Completion: 2027-12-30
• First posted: 2023-11-18
• Last updated: 2026-04-16

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study